Literature DB >> 1355154

Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia.

K Kilidireas1, N Latov, D H Strauss, A D Gorig, G A Hashim, J M Gorman, S A Sadiq.   

Abstract

Immune mechanisms are thought to be important in a subpopulation of patients with schizophrenia. We examined the specificity of neural antibodies in patients with schizophrenia to identify a possible antigen. Serum antibodies from patients with schizophrenia and control subjects were tested for binding to protein extracts of human neuroblastoma cells by western blot. Protein antigens were characterised by aminoterminal and internal aminoacid sequence analysis. 14 of 32 (44%) otherwise healthy patients with schizophrenia had antibodies to a neuroblastoma protein of molecular weight 60 kDa. By partial sequence analysis, this protein was identified as the 60 kDa human heat-shock protein (hsp) that is the P1 mitochondrial protein, and which is 50% homologous to the mycobacterial 65 kDa hsp. Antigens that crossreact with hsp65 have been implicated in the pathogenesis of adjuvant-induced arthritis in rats and autoimmune diabetes in mice. Of 100 normal subjects or disease controls, antibodies to hsp60 were found in only 8 patients, all of whom had active infectious or inflammatory disease. Our results support the presence of abnormal immune reactivity involving hsp60 in a subset of patients with schizophrenia. The immune response may be related to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355154     DOI: 10.1016/0140-6736(92)92105-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Role of viral infections in the inception of childhood asthma and allergies.

Authors:  J M Grange; J L Stanford; G A Rook; P Wright
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

Review 2.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 3.  Can environmental factors explain the epidemiology of schizophrenia in immigrant groups?

Authors:  S Gupta
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-11       Impact factor: 4.328

4.  Cross-reactivity of Antibodies Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae With Heat Shock Protein 60 and ATP-Binding Protein Correlates to Reduced Mitochondrial Activity in HIBCPP Choroid Plexus Papilloma Cells.

Authors:  B Reuss; H Schroten; H Ishikawa; A R Asif
Journal:  J Mol Neurosci       Date:  2015-06-17       Impact factor: 3.444

Review 5.  Schizophrenia and Alarmins.

Authors:  Huan Ma; Ning Cheng; Caiyi Zhang
Journal:  Medicina (Kaunas)       Date:  2022-05-24       Impact factor: 2.948

Review 6.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Antibodies directed to the gram-negative bacterium Neisseria gonorrhoeae cross-react with the 60 kDa heat shock protein and lead to impaired neurite outgrowth in NTera2/D1 cells.

Authors:  B Reuss; A R Asif
Journal:  J Mol Neurosci       Date:  2014-02-28       Impact factor: 3.444

8.  Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status.

Authors:  Roberto Delle Chiaie; Brunella Caronti; Francesco Macrì; Sandra Campi; Marzia Marino; Alessandra Corrado; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-08-23

Review 9.  The danger model approach to the pathogenesis of the rheumatic diseases.

Authors:  César Pacheco-Tena; Susana Aideé González-Chávez
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

10.  Brain antibodies in the cortex and blood of people with schizophrenia and controls.

Authors:  L J Glass; D Sinclair; D Boerrigter; K Naude; S J Fung; D Brown; V S Catts; P Tooney; M O'Donnell; R Lenroot; C Galletly; D Liu; T W Weickert; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.